Meeting
2022 ASCO Genitourinary Cancers Symposium
Long-term cost comparisons of radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer.
Authors
Vishnukamal Golla
Duke University, Durham, NC
Vishnukamal Golla , Yong Shan , Elias Joseph Farran , Kevin Vu , Courtney A. Stewart , Ali Raza Khaki , Kirk A. Keegan , Ashish M. Kamat , Douglas S. Tyler , Stephen J. Freedland , Stephen B. Williams
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Urothelial Carcinoma
Track
Urothelial Carcinoma
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 455)
DOI
10.1200/JCO.2022.40.6_suppl.455
Abstract #
455
Poster Bd #
C9
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Cost-effectiveness of radical cystectomy versus trimodality therapy for muscle invasive bladder cancer.
First Author: Nathan Suskovic
Poster
2019 ASCO Annual Meeting
National cancer expenditure analysis in the United States Medicare population, 2013.
First Author: Emily S Ruiz
Poster
2019 Genitourinary Cancers Symposium
Comparing costs of radical cystectomy versus trimodal therapy for patients diagnosed with localized muscle-invasive bladder cancer.
First Author: Mohamed Danny Ray-Zack
Poster
2014 Genitourinary Cancers Symposium
Radical cystectomy versus trimodality bladder-preserving therapy for muscle-invasive bladder cancer among elderly (80-84 years old) patients.
First Author: Shingo Hatakeyama